Esmaeilzadeh Holding comments on extended bank facility and changed capital structure in Lyvia Group

Net debt/EBITDA at Lyvia is expected to decrease from ~5.2x to ~4.5x after additional earn-outs and convertible instruments are converted into shares via set-off subscriptions (a ~0.7x, ≈13% reduction in leverage). The equity conversions reduce Lyvia’s debt burden and improve balance-sheet flexibility, a company-specific positive that could modestly support the share price and credit profile.

Analysis

The recent balance-sheet repair materially shifts the set of realistic strategic outcomes for Lyvia: refinancing risk and forced asset sales are meaningfully lower, which increases odds of a voluntary strategic path (bolt-on M&A or multi-year operational improvement) rather than a distressed resolution. Lower leverage also compresses the credit spread premium the market will demand for the next 12–18 months; treat current spread tightening as partially transient and linked to technical deleveraging rather than sustained EBITDA re-rating.

Immediate winners are stakeholders who monetize liquidity (senior creditors, working-capital suppliers) and any buyers in a potential auction process — the company can now transact with less price concession. Second-order beneficiaries include upstream suppliers and long-cycle capex vendors previously sidelined by covenant risk, because reduced default probability makes multi-year contracts feasible again. Conversely, direct competitors that trade on a higher-late-cycle premium lose optionality advantage if Lyvia uses its headroom to pursue market consolidation.

Key risks: operational downside that leaves EBITDA flat will re-open refinancing stress because the improvement is balance-sheet engineering rather than a secular earnings shift; covenant resets or legal challenges from minority holders over conversion mechanics are realistic 3–9 month tails. Catalysts to monitor over the next 6–18 months are audited quarterly EBITDA prints, any announced refinancing/credit documentation, and shareholder votes that reveal dilution appetite or new strategic plans.

From a portfolio perspective, this is a classic “de-risked equity optionality” setup — the trade is to capture re-rating if execution follows while protecting against an operational relapse. Position sizing and instrument choice should reflect the asymmetric nature of balance-sheet fixes: limited incremental equity dilution now buys convexity on successful execution, but downside remains severe if EBITDA disappoints.

Key Decisions for Investors

• Long EHAB (Esmaeilzadeh Holding AB) equity — 6–18 month horizon. Size 3–5% NAV. Rationale: capture re-rating as refinancing risk fades; target +30–60% upside if management delivers two consecutive quarters of EBITDA growth; hard stop -35% on failure to meet covenant-adjusted guidance or missed Qs.
• Participate in any new equity/set-off issuance or subscribe rights where available — near-term opportunity. Deploy up to 2% NAV at issuance price to secure upside with downside protection (new shares priced below post-repair fair value); reward-to-risk ~3:1 if issuance price < 70% of implied post-repair valuation.
• Credit pair: long senior-secured paper / short unsecured paper of Lyvia (or equivalent) — 12–24 months. If available, expected spread compression on secured bonds 100–250bps; short unsecured to hedge macro-credit risk. Size as credit-neutral tranche; stop if senior spreads widen >150bps or EBITDA revision downward.
• Relative-value equity pair: long EHAB / short a higher-leverage listed peer in same vertical — 6–12 months. Aim to capture multiple convergence (expected 300–500bps spread tightening) while hedging sector cyclicality. Use equal-dollar sizing and close on announcement of M&A or 2nd consecutive positive earnings surprise.